Report Detail

Medical Industry Global NTRK Fusion Gene Positive Advanced Solid Tumor Market Growth (Status and Outlook) 2021-2026

  • RnM4354277
  • |
  • 15 November, 2021
  • |
  • Global
  • |
  • 106 Pages
  • |
  • LPI(LP Information)
  • |
  • Medical Industry

1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered

2 Executive Summary

  • 2.1 World Market Overview
    • 2.1.1 Global NTRK Fusion Gene Positive Advanced Solid Tumor Market Size 2016-2026
    • 2.1.2 NTRK Fusion Gene Positive Advanced Solid Tumor Market Size CAGR by Region 2020 VS 2021 VS 2026
  • 2.2 NTRK Fusion Gene Positive Advanced Solid Tumor Segment by Type
    • 2.2.1 Therapeutics
    • 2.2.2 Therapeutics
  • 2.3 NTRK Fusion Gene Positive Advanced Solid Tumor Market Size by Type
    • 2.3.1 Global NTRK Fusion Gene Positive Advanced Solid Tumor Market Size CAGR by Type
    • 2.3.2 Global NTRK Fusion Gene Positive Advanced Solid Tumor Market Size Market Share by Type (2016-2021)
  • 2.4 NTRK Fusion Gene Positive Advanced Solid Tumor Segment by Application
    • 2.4.1 Hospitals and Clinics
    • 2.4.2 Cancer Centers
    • 2.4.3 Others
  • 2.5 NTRK Fusion Gene Positive Advanced Solid Tumor Market Size by Application
    • 2.5.1 Global NTRK Fusion Gene Positive Advanced Solid Tumor Market Size CAGR by Application
    • 2.5.2 Global NTRK Fusion Gene Positive Advanced Solid Tumor Market Size Market Share by Application (2016-2021)

3 NTRK Fusion Gene Positive Advanced Solid Tumor Market Size by Players

  • 3.1 NTRK Fusion Gene Positive Advanced Solid Tumor Market Size Market Share by Players
    • 3.1.1 Global NTRK Fusion Gene Positive Advanced Solid Tumor Revenue by Players (2019-2021E)
    • 3.1.2 Global NTRK Fusion Gene Positive Advanced Solid Tumor Revenue Market Share by Players (2019-2021E)
  • 3.2 Global NTRK Fusion Gene Positive Advanced Solid Tumor Key Players Head office and Products Offered
  • 3.3 Market Concentration Rate Analysis
    • 3.3.1 Competition Landscape Analysis
    • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
  • 3.4 New Products and Potential Entrants
  • 3.5 Mergers & Acquisitions, Expansion

4 NTRK Fusion Gene Positive Advanced Solid Tumor by Regions

  • 4.1 NTRK Fusion Gene Positive Advanced Solid Tumor Market Size by Regions (2016-2021)
  • 4.2 Americas NTRK Fusion Gene Positive Advanced Solid Tumor Market Size Growth (2016-2021)
  • 4.3 APAC NTRK Fusion Gene Positive Advanced Solid Tumor Market Size Growth (2016-2021)
  • 4.4 Europe NTRK Fusion Gene Positive Advanced Solid Tumor Market Size Growth (2016-2021)
  • 4.5 Middle East & Africa NTRK Fusion Gene Positive Advanced Solid Tumor Market Size Growth (2016-2021)

5 Americas

  • 5.1 Americas NTRK Fusion Gene Positive Advanced Solid Tumor Market Size by Country (2016-2021)
  • 5.2 Americas NTRK Fusion Gene Positive Advanced Solid Tumor Market Size by Type (2016-2021)
  • 5.3 Americas NTRK Fusion Gene Positive Advanced Solid Tumor Market Size by Application (2016-2021)
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil

6 APAC

  • 6.1 APAC NTRK Fusion Gene Positive Advanced Solid Tumor Market Size by Region (2016-2021)
  • 6.2 APAC NTRK Fusion Gene Positive Advanced Solid Tumor Market Size by Type (2016-2021)
  • 6.3 APAC NTRK Fusion Gene Positive Advanced Solid Tumor Market Size by Application (2016-2021)
  • 6.4 China
  • 6.5 Japan
  • 6.6 Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia

7 Europe

  • 7.1 Europe NTRK Fusion Gene Positive Advanced Solid Tumor by Country (2016-2021)
  • 7.2 Europe NTRK Fusion Gene Positive Advanced Solid Tumor Market Size by Type (2016-2021)
  • 7.3 Europe NTRK Fusion Gene Positive Advanced Solid Tumor Market Size by Application (2016-2021)
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia

8 Middle East & Africa

  • 8.1 Middle East & Africa NTRK Fusion Gene Positive Advanced Solid Tumor by Region (2016-2021)
  • 8.2 Middle East & Africa NTRK Fusion Gene Positive Advanced Solid Tumor Market Size by Type (2016-2021)
  • 8.3 Middle East & Africa NTRK Fusion Gene Positive Advanced Solid Tumor Market Size by Application (2016-2021)
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers and Impact
    • 9.1.1 Growing Demand from Key Regions
    • 9.1.2 Growing Demand from Key Applications and Potential Industries
  • 9.2 Market Challenges and Impact
  • 9.3 Market Trends

10 Global NTRK Fusion Gene Positive Advanced Solid Tumor Market Forecast

  • 10.1 Global NTRK Fusion Gene Positive Advanced Solid Tumor Forecast by Regions (2021-2026)
    • 10.1.1 Global NTRK Fusion Gene Positive Advanced Solid Tumor Forecast by Regions (2021-2026)
    • 10.1.2 Americas NTRK Fusion Gene Positive Advanced Solid Tumor Forecast
    • 10.1.3 APAC NTRK Fusion Gene Positive Advanced Solid Tumor Forecast
    • 10.1.4 Europe NTRK Fusion Gene Positive Advanced Solid Tumor Forecast
    • 10.1.5 Middle East & Africa NTRK Fusion Gene Positive Advanced Solid Tumor Forecast
  • 10.2 Americas NTRK Fusion Gene Positive Advanced Solid Tumor Forecast by Countries (2021-2026)
    • 10.2.1 United States NTRK Fusion Gene Positive Advanced Solid Tumor Market Forecast
    • 10.2.2 Canada NTRK Fusion Gene Positive Advanced Solid Tumor Market Forecast
    • 10.2.3 Mexico NTRK Fusion Gene Positive Advanced Solid Tumor Market Forecast
    • 10.2.4 Brazil NTRK Fusion Gene Positive Advanced Solid Tumor Market Forecast
  • 10.3 APAC NTRK Fusion Gene Positive Advanced Solid Tumor Forecast by Region (2021-2026)
    • 10.3.1 China NTRK Fusion Gene Positive Advanced Solid Tumor Market Forecast
    • 10.3.2 Japan NTRK Fusion Gene Positive Advanced Solid Tumor Market Forecast
    • 10.3.3 Korea NTRK Fusion Gene Positive Advanced Solid Tumor Market Forecast
    • 10.3.4 Southeast Asia NTRK Fusion Gene Positive Advanced Solid Tumor Market Forecast
    • 10.3.5 India NTRK Fusion Gene Positive Advanced Solid Tumor Market Forecast
    • 10.3.6 Australia NTRK Fusion Gene Positive Advanced Solid Tumor Market Forecast
  • 10.4 Europe NTRK Fusion Gene Positive Advanced Solid Tumor Forecast by Country (2021-2026)
    • 10.4.1 Germany NTRK Fusion Gene Positive Advanced Solid Tumor Market Forecast
    • 10.4.2 France NTRK Fusion Gene Positive Advanced Solid Tumor Market Forecast
    • 10.4.3 UK NTRK Fusion Gene Positive Advanced Solid Tumor Market Forecast
    • 10.4.4 Italy NTRK Fusion Gene Positive Advanced Solid Tumor Market Forecast
    • 10.4.5 Russia NTRK Fusion Gene Positive Advanced Solid Tumor Market Forecast
  • 10.5 Middle East & Africa NTRK Fusion Gene Positive Advanced Solid Tumor Forecast by Region (2021-2026)
    • 10.5.1 Egypt NTRK Fusion Gene Positive Advanced Solid Tumor Market Forecast
    • 10.5.2 South Africa NTRK Fusion Gene Positive Advanced Solid Tumor Market Forecast
    • 10.5.3 Israel NTRK Fusion Gene Positive Advanced Solid Tumor Market Forecast
    • 10.5.4 Turkey NTRK Fusion Gene Positive Advanced Solid Tumor Market Forecast
    • 10.5.5 GCC Countries NTRK Fusion Gene Positive Advanced Solid Tumor Market Forecast
  • 10.6 Global NTRK Fusion Gene Positive Advanced Solid Tumor Forecast by Type (2021-2026)
  • 10.7 Global NTRK Fusion Gene Positive Advanced Solid Tumor Forecast by Application (2021-2026)

11 Key Players Analysis

  • 11.1 Bayer
    • 11.1.1 Bayer Company Information
    • 11.1.2 Bayer NTRK Fusion Gene Positive Advanced Solid Tumor Product Offered
    • 11.1.3 Bayer NTRK Fusion Gene Positive Advanced Solid Tumor Revenue, Gross Margin and Market Share (2019-2021)
    • 11.1.4 Bayer Main Business Overview
    • 11.1.5 Bayer Latest Developments
  • 11.2 Teva Pharmaceuticals
    • 11.2.1 Teva Pharmaceuticals Company Information
    • 11.2.2 Teva Pharmaceuticals NTRK Fusion Gene Positive Advanced Solid Tumor Product Offered
    • 11.2.3 Teva Pharmaceuticals NTRK Fusion Gene Positive Advanced Solid Tumor Revenue, Gross Margin and Market Share (2019-2021)
    • 11.2.4 Teva Pharmaceuticals Main Business Overview
    • 11.2.5 Teva Pharmaceuticals Latest Developments
  • 11.3 Empire Genomics
    • 11.3.1 Empire Genomics Company Information
    • 11.3.2 Empire Genomics NTRK Fusion Gene Positive Advanced Solid Tumor Product Offered
    • 11.3.3 Empire Genomics NTRK Fusion Gene Positive Advanced Solid Tumor Revenue, Gross Margin and Market Share (2019-2021)
    • 11.3.4 Empire Genomics Main Business Overview
    • 11.3.5 Empire Genomics Latest Developments
  • 11.4 SeraCare Life Sciences
    • 11.4.1 SeraCare Life Sciences Company Information
    • 11.4.2 SeraCare Life Sciences NTRK Fusion Gene Positive Advanced Solid Tumor Product Offered
    • 11.4.3 SeraCare Life Sciences NTRK Fusion Gene Positive Advanced Solid Tumor Revenue, Gross Margin and Market Share (2019-2021)
    • 11.4.4 SeraCare Life Sciences Main Business Overview
    • 11.4.5 SeraCare Life Sciences Latest Developments
  • 11.5 F. Hoffmann-La Roche
    • 11.5.1 F. Hoffmann-La Roche Company Information
    • 11.5.2 F. Hoffmann-La Roche NTRK Fusion Gene Positive Advanced Solid Tumor Product Offered
    • 11.5.3 F. Hoffmann-La Roche NTRK Fusion Gene Positive Advanced Solid Tumor Revenue, Gross Margin and Market Share (2019-2021)
    • 11.5.4 F. Hoffmann-La Roche Main Business Overview
    • 11.5.5 F. Hoffmann-La Roche Latest Developments
  • 11.6 NeoGenomics Laboratories
    • 11.6.1 NeoGenomics Laboratories Company Information
    • 11.6.2 NeoGenomics Laboratories NTRK Fusion Gene Positive Advanced Solid Tumor Product Offered
    • 11.6.3 NeoGenomics Laboratories NTRK Fusion Gene Positive Advanced Solid Tumor Revenue, Gross Margin and Market Share (2019-2021)
    • 11.6.4 NeoGenomics Laboratories Main Business Overview
    • 11.6.5 NeoGenomics Laboratories Latest Developments
  • 11.7 Glaxosmithkline
    • 11.7.1 Glaxosmithkline Company Information

According to this latest study, the 2021 growth of NTRK Fusion Gene Positive Advanced Solid Tumor will have significant change from previous year. By the most conservative estimates of global NTRK Fusion Gene Positive Advanced Solid Tumor market size (most likely outcome) will be a year-over-year revenue growth rate of % in 2021, from US$ million in 2020. Over the next five years the NTRK Fusion Gene Positive Advanced Solid Tumor market will register a % CAGR in terms of revenue, the global market size will reach US$ million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of NTRK Fusion Gene Positive Advanced Solid Tumor market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
Therapeutics
Diagnostics

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
Hospitals and Clinics
Cancer Centers
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Bayer
Teva Pharmaceuticals
Empire Genomics
SeraCare Life Sciences
F. Hoffmann-La Roche
NeoGenomics Laboratories
Glaxosmithkline
OncoDNA
Merck & Co.
Daiichi Sankyo
S Deciphera Pharmaceuticals


Summary:
Get latest Market Research Reports on NTRK Fusion Gene Positive Advanced Solid Tumor. Industry analysis & Market Report on NTRK Fusion Gene Positive Advanced Solid Tumor is a syndicated market report, published as Global NTRK Fusion Gene Positive Advanced Solid Tumor Market Growth (Status and Outlook) 2021-2026. It is complete Research Study and Industry Analysis of NTRK Fusion Gene Positive Advanced Solid Tumor market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

Last updated on

REPORT YOU MIGHT BE INTERESTED

Purchase this Report

$3,500.00
$7,000.00
2,646.00
5,292.00
3,108.00
6,216.00
397,460.00
794,920.00
264,355.00
528,710.00
Credit card Logo

Related Reports


Reason to Buy

Request for Sample of this report